Literature DB >> 8035403

Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes.

J Guzmán1, R E Petty, P N Malleson.   

Abstract

OBJECTIVE: To assess the usefulness of serial measurement of plasma von Willebrand factor (vWF) and serum levels of muscle enzymes in the detection and prediction of flares of disease activity in children with juvenile dermatomyositis (JDM).
METHODS: Retrospective study of serial measurements of vWF and muscle enzymes in 16 patients with JDM followed for 540 patient-months. Charts were reviewed by an investigator blinded to laboratory results, and disease flare was defined as 2 of worsening function, increasing weakness, increasing muscle enzymes, increasing medication requirements.
RESULTS: vWF was increased on at least one occasion in all but 2 patients with levels up to 4.9 IU/ml (normal 0.5 to 1.5). Laboratory evaluations were available in 23/29 disease flares. The sensitivity (0.85) and specificity (0.45) of vWF to detect disease flare were not better than that of LDH or AST even when muscle enzyme levels were excluded from flare definition. CK and ALT were not significantly associated with disease flare. The risk of flare increased 3-fold after a > 20% increase in AST levels, but vWF did not reliably predict disease flare.
CONCLUSION: Although vWF is associated with disease flares, it does not seem to offer more information than enzyme measurements. LDH and AST were most useful in the detection of a flare, while AST was the only test capable of predicting it.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035403

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

Review 1.  Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.

Authors:  Angela B Robinson; Ann M Reed
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

Review 2.  Treatment of inflammatory myopathies.

Authors:  A C Cordeiro; D A Isenberg
Journal:  Postgrad Med J       Date:  2006-07       Impact factor: 2.401

Review 3.  Paediatric idiopathic inflammatory muscle disease: recognition and management.

Authors:  Clarissa A Pilkington; Lucy R Wedderburn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Clinical significance of von Willebrand factor in patients with adult dermatomyositis.

Authors:  Toshiyuki Komiya; Nobuo Negoro; Kyoko Kondo; Katsuyuki Miura; Yoshio Hirota; Junichi Yoshikawa
Journal:  Clin Rheumatol       Date:  2004-11-23       Impact factor: 2.980

5.  Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-oj antibody-positive polymyositis: a case report.

Authors:  Kan-Hsuan Lin; Jun-Kai Kao
Journal:  Pediatr Rheumatol Online J       Date:  2022-10-21       Impact factor: 3.413

6.  Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis.

Authors:  Takayuki Kishi; Jonathan Chipman; Melvina Evereklian; Khanh Nghiem; Maryalice Stetler-Stevenson; Margaret E Rick; Michael Centola; Frederick W Miller; Lisa G Rider
Journal:  J Rheumatol       Date:  2019-08-01       Impact factor: 4.666

Review 7.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

8.  Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study.

Authors:  Rohit Loomba; Shih-Jen Hwang; Christopher J O'Donnell; R Curtis Ellison; Ramachandran S Vasan; Ralph B D'Agostino; T Jake Liang; Caroline S Fox
Journal:  Gastroenterology       Date:  2008-01-18       Impact factor: 22.682

9.  The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.

Authors:  Dragana Lazarevic; Angela Pistorio; Elena Palmisani; Paivi Miettunen; Angelo Ravelli; Clarissa Pilkington; Nico M Wulffraat; Clara Malattia; Stella Maris Garay; Michael Hofer; Pierre Quartier; Pavla Dolezalova; Inmaculada Calvo Penades; Virginia P L Ferriani; Gerd Ganser; Ozgur Kasapcopur; Jose Antonio Melo-Gomes; Ann M Reed; Malgorzata Wierzbowska; Lisa G Rider; Alberto Martini; Nicolino Ruperto
Journal:  Ann Rheum Dis       Date:  2012-06-26       Impact factor: 19.103

Review 10.  Consensus-based recommendations for the management of juvenile dermatomyositis.

Authors:  Felicitas Bellutti Enders; Brigitte Bader-Meunier; Eileen Baildam; Tamas Constantin; Pavla Dolezalova; Brian M Feldman; Pekka Lahdenne; Bo Magnusson; Kiran Nistala; Seza Ozen; Clarissa Pilkington; Angelo Ravelli; Ricardo Russo; Yosef Uziel; Marco van Brussel; Janjaap van der Net; Sebastiaan Vastert; Lucy R Wedderburn; Nicolaas Wulffraat; Liza J McCann; Annet van Royen-Kerkhof
Journal:  Ann Rheum Dis       Date:  2016-08-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.